Monday, January 30, 2023
No Result
View All Result
  • Home
  • Recent
  • Business
  • Economy
  • Investing
  • Markets
  • Personal Finance
  • Retirement
  • Tech
  • Startups
  • Insurance
  • Market Research
  • Crypto
  • Home
  • Recent
  • Business
  • Economy
  • Investing
  • Markets
  • Personal Finance
  • Retirement
  • Tech
  • Startups
  • Insurance
  • Market Research
  • Crypto
No Result
View All Result
Home Latest updates

For GSK, breaking up isnt hard to do as consumer health unit Haleon launches Monday (GSK)

Updates Finance by Updates Finance
July 16, 2022
in Latest updates
0
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


You might also like

Joshimath: Chamoli DM suggests three options for settlement of displaced people

J&J Can’t Use Bankruptcy to Resolve Talc-Injury Lawsuits, Appeals Court Rules

Ford drops prices on electric Mustang to stay within range of Tesla

Leon Neal/Getty Images News

Monday, July 18, is set to be a big day for GlaxoSmithKline (NYSE:GSK) — and the London Stock Exchange — as the UK pharma giant’s consumer health unit trades as a separate company, Haleon.

Familiar brands such as Centrum vitamins, Advil pain medication, Robitussin cough syrup, TUMS antacid, and Aquafresh and Sensodyne toothpastes will fall under the Haleon name. Brian McNamara, who heads GSK (GSK) Consumer Healthcare, will become Haleon CEO.

Although Haleon is seen as having a market capitalization of more than $52B, it will also carry debt to the tune of ~£10.3B (~$12.2B).

GSK (GSK) CEO Emma Walmsley knows a thing or two about consumer health as she held various roles at L’Oreal before joining GSK (GSK) in 2010. But she’s not moving to Haleon.

The demerger allows legacy GSK (GSK) to focus on prescription pharmaceuticals and vaccines. Investors will be paying close attention to “old” GSK (GSK) which has come under more than its fair share of criticism since Walmsley took over the reins in 2017.

In 2021, activist investors Elliott Investment Management and Bluebell Capital Partners heavily criticized Walmsley’s stewardship.

She will be under tremendous pressure to right the ship given GSK’s (GSK) performance compared to its peers over the last five years. Only Bayer (OTCPK:BAYZF), whose business spans beyond pharmaceuticals, has performed worse.

5-year price return for selected European pharma stocks

Like other large pharmas, M&A will be on Walmsley’s radar. In late May, GSK (GSK) said it was buying pneumococcal vaccine maker Affinivax for a $2.1B upfront.

Springworks Therapeutics (SWTX) could be a target, according to Reuters, as the pharma giant already has a partnership with the oncology and rare disease biotech for nirogacestat for multiple myeloma.

GSK has benefitted particularly from sales increases in its speciality medicines division — at £3.1B (~$3.7B) in revenue in Q1 2022, it was the biggest driver — as well as vaccines. The shingles vaccines Shingrix accounted for 41% of the £1.7B (~$2B) in vaccine sales in the quarter.

The company’s late-stage pipeline has several candidates that could add significantly to the bottom line. Among these are a respiratory syncytial virus vaccine, otilimab in rheumatoid arthritis, and depemokimab for severe eosinophilic asthma.

At least some of the late-stage pipeline will need to come through as GSK (GSK) will lose patent protection on dolutegravir, a drug found in several of its HIV treatments, in 2027. That could lead to a significant loss of revenue.

Regarding Haleon, management has stated a goal of increasing net sales at 4%-6% annually. Net debt/adjusted EBITDA is targeted at <3x by the end 2024. At the outset, the initial dividend is expected to be at lower end of a 30%-50% pay-out ratio range.

Given the current inflationary environment, 4%-6% growth may not seem all that attractive to many investors. Pfizer (PFE), which has a 32% stake in Haleon, said it will exit it after the demerger.

Some investors who will receive Haleon shares will likely act in a similar fashion. Seeking Alpha contributor George Theodosi makes the argument for why he will likely sell Haleon shares after the spinoff.



Source link

Tags: breakingConsumerGSKHaleonHardhealthIsntlaunchesMondayUnit
Share30Tweet19
Updates Finance

Updates Finance

Recommended For You

Joshimath: Chamoli DM suggests three options for settlement of displaced people

by Updates Finance
January 30, 2023
0

Joshimath crisis: Chamoli District Magistrate Himanshu Khurana on Monday suggested three options for the settlement of the displaced people in land subsidence-hit Joshimath, officials said. Khurana who heads a...

Read more

J&J Can’t Use Bankruptcy to Resolve Talc-Injury Lawsuits, Appeals Court Rules

by Updates Finance
January 30, 2023
0

A federal appeals court rejected Johnson & Johnson ‘s plan to use a legal strategy to push about 38,000 talc lawsuits into bankruptcy court, hampering the controversial tactic...

Read more

Ford drops prices on electric Mustang to stay within range of Tesla

by Updates Finance
January 30, 2023
0

Justin Sullivan/Getty Images News Ford Motor (NYSE:F) lowered pricing on the electric Mustang Mach-E crossover by an average of $4.5K. The biggest price cut on a dollar basis...

Read more

Swedish and Finnish Nato bids may be treated ‘separately’, Turkey warns

by Updates Finance
January 30, 2023
0

Turkey has suggested supporting the bid by Finland to join Nato while blocking Sweden, highlighting the deteriorating relations between Ankara and Stockholm after a rightwing activist desecrated a...

Read more

South Korea Jan exports to extend falling streak to fourth month

by Updates Finance
January 30, 2023
0

Breadcrumb Trail Links PMN Business Article content SEOUL — South Korea’s January export data will likely show an annual fall for a fourth straight month, with the pace...

Read more
Next Post

SEC Fines John McAfee's Associate $375K in Penalties for ICO Promotions – Bitcoin News

Related News

Microsoft OneNote cheat sheet | Computerworld

August 24, 2022

Ukrainians celebrate retaking of Kherson By Reuters

November 12, 2022

Maxeon Solar: Big US-Focused Manufacturing Plans For This Global Solar Power Producer

August 8, 2022

Browse by Category

  • Business
  • Cryptocurrency
  • Economy
  • Insurance
  • Investing
  • Latest updates
  • Market Research
  • Markets
  • Personal Finance
  • Retirement
  • Startups
  • Technology

Get the latest Financial news on updatesfinance.com. Business news, Economy news, Investing news, Personal Finance and more.

CATEGORIES

  • Business
  • Cryptocurrency
  • Economy
  • Insurance
  • Investing
  • Latest updates
  • Market Research
  • Markets
  • Personal Finance
  • Retirement
  • Startups
  • Technology

Recent News

  • Tech, megacaps drag Wall St lower at start of big market week By Reuters
  • Joshimath: Chamoli DM suggests three options for settlement of displaced people

Copyright © 2022 - Updates Finance..

No Result
View All Result
  • Home
  • DMCA
  • Disclaimer
  • Cookie Privacy Policy
  • Privacy Policy
  • Terms and Conditions
  • Contact us

Copyright © 2022 - Updates Finance..

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?